Infectious Diseases

August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]

March 9, 2016

March 8, 2016

March 8, 2016

March 7, 2016

March 2, 2016

February 23, 2016

February 22, 2016

February 22, 2016

February 17, 2016

February 16, 2016

February 10, 2016
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community